Starboard has approached two former Pfizer executives, Ian Read and Frank D’Amelio, to assist in its efforts, and they have ...

Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...

Among the large drugmakers, Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer are worth retaining in one’s portfolio.

An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country ...

AbbVie’s immunology duo Skyrizi and Rinvoq is, in a rare blip this year, not leading the pharma DTC monthly rankings as ...

Activist investor Starboard Value is looking to shake up pharma giant Pfizer's sagging stock price.

Pfizer (PFE) stock may present opportunities for patient investors. Read how this biotech giant may deliver long-term ...

Citing people familiar with the matter, The Journal reported that Starboard approached former Pfizer CEO Ian Read and CFO ...

The week has started with reports that activist investor Starboard Value has amassed a $1 billion stake in pharma group ...

On top of this, Pfizer also faces key patent expirations of certain older products, and earlier estimated this will result in ...